|
US5418223A
|
|
Method for lyophilization of cyclophosphamide and product
|
|
US5336669A
|
|
Cyclophosphamide monohydrate and lactose
|
|
NZ244322A
|
|
Use of rifabutin to prepare medicaments for the treatment/prevention of mycobacterial infections
|
|
CA2063058A1
|
|
Process for hydrating lyophilized compositions using atomized water
|
|
US5268368A
|
|
Cyclophosphamide--amino acid lyophilizates
|
|
US5122528A
|
|
Analgesic use of benzobicyclic carboxamides
|
|
US5114947A
|
|
Method for alleviating anxiety using benzobicyclic carboxamides
|
|
US5130305A
|
|
Cyclophosphamide - sodium bicarbonate lyophilizates
|
|
US5066647A
|
|
Cyclophosphamide - alanine lyophilizates
|
|
US5126364A
|
|
4-amino-5-chloro-n-(2-pyrrolidinylmethyl)-2,3-dihydrobenzo[b]furan-7-carboxamide and pharmaceutical compositions containing the same
|
|
US5091175A
|
|
Pharmaceutical composition containing bile acid sequestrant enclosed in a size-exclusion membrane
|
|
CA2013474A1
|
|
Cyclophosphamide - alanine lyophilizates
|
|
US4963551A
|
|
Stable lyophilized form of (S)-(+)-bis-4,4'-(1-methyl-1,2-ethanediyl)2,6-piperazinedione and solutions thereof
|
|
CA2001643A1
|
|
Preservative-free multi-dose vincristine solution
|
|
US4950766A
|
|
Preparation of benzamides useful as antiemetic agents
|
|
US5002774A
|
|
Sustained release pharmaceutical tablet
|
|
EP0337599A1
|
|
Compounds and pharmaceutical preparations useful in reduction of the severity of 3'-azido-3'-deoxythymidine-induced anaemia
|
|
US5013547A
|
|
Anticancer drug - antibody conjugates and method for preparing same
|
|
EP0314483A1
|
|
Preparation of benzamides
|
|
US4963679A
|
|
Process for preparing bis (3,5-dioxopiperazinyl) alkanes or alkenes
|
